إعلان
إعلان
BIAF
bioAffinity Technologies, Inc. Common Stock
1.29
USDبرعاية
0.00
-0.23%
٠٨ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
1.29
+0.01
+0.54%
تقارير أرباح BIAF
النسبة الإيجابية المفاجئة
BIAF تفوق 1 من 6 آخر التقديرات.
17%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$1.58M
/-$2.75
التغير الضمني من Q3 25 (Revenue/ EPS)
+9.55%
/-41.98%
التغير الضمني من Q4 24 (Revenue/ EPS)
-28.26%
/-56.35%
bioAffinity Technologies, Inc. Common Stock earnings per share and revenue
On ١٤ نوفمبر ٢٠٢٥, BIAF reported earnings of -4.74 USD per share (EPS) for Q3 25, missing the estimate of -2.75 USD, resulting in a -72.11% surprise. Revenue reached 1.45 مليون, compared to an expected 1.44 مليون, with a 0.47% difference. The market reacted with a -2.13% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -2.75 USD, with revenue projected to reach 1.58 مليون USD, implying an نقصان of -41.98% EPS, and زيادة of 9.55% in Revenue from the last quarter.
الأسئلة الشائعة
What were bioAffinity Technologies, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, bioAffinity Technologies, Inc. Common Stock reported EPS of -$4.74, missing estimates by -72.11%, and revenue of $1.45M, 0.47% above expectations.
How did the market react to bioAffinity Technologies, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.13%, changed from $1.88 before the earnings release to $1.84 the day after.
When is bioAffinity Technologies, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for bioAffinity Technologies, Inc. Common Stock's next earnings report?
Based on 3
المحللين, bioAffinity Technologies, Inc. Common Stock is expected to report EPS of -$2.75 and revenue of $1.58M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان